Skip to content

Understanding peptide drug pricing is essential for healthcare planning, formulary decisions, and patient access. This analysis covers per-dose costs, annual treatment expenses, and the impact of biosimilar competition on market pricing.

PeptideDoseCost/DoseFrequencyAnnual Cost
Semaglutide (Ozempic)1 mg~$300Weekly~$15,600
Liraglutide (Victoza)1.8 mg~$45Daily~$16,400
Insulin glargine20 units~$15Daily~$5,500
Insulin lispro10 units~$10Per meal~$10,900
Tirzepatide (Mounjaro)5 mg~$320Weekly~$16,640
Dulaglutide (Trulicity)1.5 mg~$200Weekly~$10,400
Exenatide (Byetta)10 mcg~$15Twice daily~$10,950
Teriparatide (Forteo)20 mcg~$45Daily~$16,400
OriginatorBiosimilarSavingsYear Launched
Insulin glargine (Lantus)Basaglar~30%2015
Insulin lispro (Humalog)Admelog~25%2017
Insulin aspart (Novolog)Fiasp~20%2017
Insulin degludec (Tresiba)Absirva~25%2024
  1. Raw materials: Amino acids, reagents, solvents
  2. Manufacturing: SPPS labor, HPLC purification
  3. Quality control: Analytical testing per ICH guidelines
  4. Regulatory: Clinical trials, FDA approval
  5. Distribution: Cold chain, specialty pharmacy
  6. Intellectual property: Patent protection periods
  7. Market dynamics: Payer negotiations, rebates
CountrySemaglutide (1 mg)Insulin GlargineNotes
USA~$300/dose~$15/unitHighest prices
UK (NHS)~$90/dose~$3/unitReference pricing
Germany~$100/dose~$4/unitAMNOG process
Japan~$80/dose~$3.50/unitNHI pricing
India~$50/dose~$1/unitGeneric competition
ProgramEligibilityCoverage
Manufacturer couponsCommercial insurance$25-100/month copay
Medicare Extra HelpLow-income seniorsPremium assistance
Patient assistance foundationsUninsured/underinsuredFull coverage
340B pricingSafety-net providers25-50% discount

Cost-effective supplies available from Kingston Peptides